EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells

Molecular Biology Reports

Volumn 40, Issue 10, 2013, Pages 5587-5596

  Muthusami, Sridhar ^a   Prabakaran, D S ^a   An, Zhengzhe ^a   Yu, Jae Ran ^b   Park, Woo Yoon ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Cervical cancer; Chromatin immunoprecipitation; EGCG; Fused Toes Homolog; P53 silencing

Indexed keywords

EPIGALLOCATECHIN GALLATE; FUSED TOES HOMOLOG PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MESSENGER RNA SYNTHESIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; CATECHIN; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELA CELLS; HUMANS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84892686924     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2660-x     Document Type: Article

References (35)

1. Scatchard K, Forrest JL, Flubacher M, Cornes P, Williams C (2012) Chemotherapy for metastatic and recurrent cervical cancer. Cochrane Database Syst Rev 10. doi:10.1002/14651858
2. Monk BJ, Herzog TJ (2007) The evolution of cost effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination. Am J Obstet Gynecol 197:337-339
3. Cabrera C, Artacho R, Gimenez R (2006) Beneficial effects of green tea -A review. J Am Coll Nutr 25:79-99
4. Shimizu M, Weinstein IB (2005) Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 591:147-160
5. Shimizu M, Deguchi A, Hara Y et al (2005) EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun 334:947-953
6. Shimizu M, Deguchi A, Joe AK et al (2005) EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 5:69-78
7. Shimizu M, Deguchi A, Lim JT et al (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11:2735-2746
8. Jeong WS, Kim IW, Hu R et al (2004) Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharm Res 21:649-660
9. Hastak K, Agarwal MK, Mukhtar H et al (2005) Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 19:789-791
10. Berletch JB, Liu C, Love WK et al (2008) Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 103:509-519
11. Yang CS, Wang X, Lu G et al (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429-439
12. Yokoyama M, Noguchi M, Nakao Y et al (2004) The tea polyphenol, (-)epigallocatechin gallate effects on growth apoptosis and telomerase activity in cervical cell lines. Gynecol Oncol 92:197-204
13. Noguchi M, Yokoyama M, Watanabe S et al (2006) Inhibitory effects of the tea polyphenol (-)epigallocatechin gallate on growth of adenocarcinoma cell lines. Cancer Lett 234:135-142
14. Lesche R, Peetz A, van der Hoeven F et al (1997) Ft1, a novel gene related to ubiquitin-conjugating enzymes, is deleted in the Fused Toes mouse mutation. Mamm Genome 8:879-883
15. Peters T, Ausmeier K, Dildrop R et al (2002) The mouse Fused Toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster. Mamm Genome 13:186-188
16. Remy I, Michnick SW (2004) Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt. Mol Cell Biol 24:1493-1504
17. Xu L, Sowa ME, Chen J et al (2008) An FTS/Hook/p107(FHIP) complex interacts with and promotes endosomal clustering by the homotypic vacuolar protein sorting complex. Mol Biol Cell 19:5059-5071
18. Cinghu S, Anandharaj A, Lee HC et al (2011) FTS (Fused Toes Homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer. J Cell Physiol 226:1564-1572
19. Muthusami S, Senthilkumar K, Vignesh C et al (2011) Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. J Cell Biochem 112:1035-1045
20. Qiao Y, Cao J, Xie L, Shi X (2009) Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res 32:1309-1315
21. Anandharaj A, Cinghu S, Kim WD et al (2011) Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells. Mol Biol Rep 38:5361-5370
22. Zhang X, Zhang H, Tighiouart M et al (2008) Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int J Cancer 123:1005-1014
23. Han DW, Jung DY, Park JC et al (2010) Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application. J Biomed Mater Res A 95:424-433
24. Sah JF, Balasubramanian S, Eckert RL et al (2004) Epigallocatechin-3- gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 279:12755-12762
25. Thakur VS, Ruhul Amin AR, Paul RK et al (2010) p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Lett 296:225-232
26. Lee MH, Han DW, Hyon SH et al (2011) Apoptosis of human fibrosarcoma HT-1080cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-jB. Apoptosis 16:75-85
27. Kang SU, Lee BS, Lee SH et al (2012) Expression of NSAIDactivated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J Nutr Biochem. doi:10.1016/j.jnutbio.2012.07.003
28. Lee MH, Na H, Kim EJ et al (2012) Poly(ADP-ribosyl)ation of p53 induces gene specific transcriptional repression of MTA1. Oncogene 31:5099-5107
29. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310
30. Yu J, Wang Z, Kinzler KW et al (2003) PUMA mediates the apoptotic response of p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931-1936
31. Yoon CH, Lee ES, Lim DS et al (2009) PKR, a p53 target gene plays a crucial role in the tumor suppressor function of p53. Proc Natl Acad Sci USA 106:7852-7857
32. Elango R, Alshatwi AA (2013) Naringin induces death receptor and mitochondria mediated apoptosis in human cervical cancer (SiHa) cells. Food Chem Toxicol 51:97-105
33. Bal DG, Foerster SB, Backman DR et al (2001) Dietary change and cancer: challenges and future direction. J Nutr 131:181-185
34. Stingl JC, Ettrich T, Muche R et al (2011) Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer 11:360
35. Wade M, Li YC, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13:83-96